Events

Virtual

To contain the COVID-19 pandemic, millions of people living in conflict zones will need to be vaccinated. But what will it take to negotiate “pandemic ceasefires” when warring factions have largely abandoned conventional laws of war? Our expert panel will look at how to get life-saving vaccines to people living amid violence and political instability. Join this free, live-streamed event with Michael Fitzgerald, Editor-in-chief, Harvard Public Health Magazine; Claude Bruderlein, Director, Centre of Competence on Humanitarian Negotiation, and Adjunct Lecturer on Global Health at the Harvard T.H. Chan School of Public Health; Madeline Drexler, Journalist and Visiting Scientist at the Harvard T.H. Chan School of Public Health; Jennifer Leaning, Senior Research Fellow, FXB Center for Health and Human Rights at Harvard University, and Associate Professor of Emergency Medicine, Brigham and Women's Hospital; Esperanza Martinez, Head of COVID-19 Crisis Team, International Committee of the Red Cross, and Elana Gordon, Reporter and Producer, The World.

Virtual

In this Harvard Medical School Executive Education live virtual webinar, Sekar Kathiresan, MD will discuss his journey from being a professor and cardiologist at Harvard Medical School to becoming the co-founder and chief executive officer of Verve Therapeutics. He will discuss leading Verve through its promising preclinical studies, its recent IPO and the road ahead, and the scientific and leadership lessons learned.

Virtual

As scientists and public health experts worked to understand the virus, reporters worked to communicate to the public the state of the knowledge — an ever-shifting ground. From the transmission debate, to the origins investigation, to changes in mask guidance, to vaccine safety concerns, the COVID-19 pandemic has highlighted a particularly precarious nexus of science, politics, journalism, social media, and policy. This panel discussion will reflect on this tenuous situation, potential areas of improvement in pandemic reporting, and lessons learned from recent experience.

Virtual

Troy Norris will build upon the revenue forecasting session to discuss how to estimate development timelines and investments, production and customer acquisition costs, to forecast profit and loss for the business. Based on this, you can estimate cash flow requirements and begin to value the business under alternative scenarios. A key focus will be on the role of risk, and smart risk-taking, for driving shareholder value and value step-ups.

Virtual

Hosted by Harvard OTD and the HMS Dept. of Biomedical Informatics, this month's speaker is Michal Preminger, PhD, MBA, Head of Johnson & Johnson Innovation, East North America. This series is a monthly conversation about medicine, biology, computers, and entrepreneurship. Open to all.

Virtual

During this session, Troy Norris will discuss how to craft a fundraising roadmap that reflects your business’ cash flow needs to reach key value inflection points, at which the key risks of a business are expected to be resolved, whether they involve technical performance, clinical benefits, or customer validation. He'll cover fundraising strategies, the different types of capital available for startups, and how to identify attractive target investors. He will also look into the role of potential sources of non-dilutive funding, such as grants or partnership funding.

Virtual

The 22nd HBSHAA Annual Conference will be held virtually on November 4-5. The conference will include innovative panels and keynote speakers along with unique networking opportunities. This year, the conference is FREE to HBSHAA members, but registration is required.

Are you an academic trainee (Post-doc/PhD/MBA/MD/JD) interested in building life science startups? Are you passionate about therapeutics, diagnostics, medtech, or synthetic biology? Nucleate is a student-run nonprofit organization that facilitates the formation of new life science ventures. Our equity-free activator program supports companies that tackle the biggest challenges in human health (Bio Track) and sustainability (Eco Track). The program connects scientific trainees and business students with a world-class advisor network of startup founders, executives, venture investors, and renowned scientists. Nucleate operates in partnership with the Harvard & MIT Biotech clubs as well as various other student groups in the Boston area. Applications are due by November 1st.

Virtual

How can you effectively build, lead and motivate winning teams to drive successful innovation? Troy Norris will review examples of organizational build-out plans, how to determine what capabilities you need to have in place over the life of your venture, and whether to access these through full-time hires, contractors, advisors or partners. He’ll also explore how to attract the right partners and different types of collaborations.

Virtual

Ready to learn how to communicate effectively to external stakeholders? In this workshop, Troy Norris will discuss the key components of a winning pitch for investors and partners, and how to custom tailor your pitch for different audiences. He will discuss how to build a brand with a strong emotional connection to customers, partners and investors, that leverages your key product features and reinforces your optimal competitive positioning.

Virtual

Hosted by Harvard OTD and the HMS Dept. of Biomedical Informatics, this month's speaker is Najat S. Khan, PhD, Chief Data Science Officer, Janssen R&D Data Sciences and Global Head, Janssen R&D Strategy and Operations. This series is a monthly conversation about medicine, biology, computers, and entrepreneurship. Open to all.

Virtual

The 4th Annual Stepping Strong Trauma Research and Innovation Symposium features a keynote presentation by Cato T. Laurencin, MD, PhD, highlights from Stepping Strong Center researchers and community partners, and the announcement of the 2021-22 Stepping Strong Innovator and Breakthrough Award recipients.

Virtual

Over the past decade, there has been a dramatic growth in interest on the part of venture capital (VC) firms for in-house creation of biotech ventures. This seminar series will offer an insider's look at the exciting world of VC-led biotech company creation and will be held weekly at 6 pm (ET). Nucleate will host representatives from industry-leading VC firms to share how they approach the venture creation process in a case study format. Come learn how some of the most iconic or up-and-coming companies have been born out of these firms. Register and Zoom info will be shared upon completion of the registration form.

Virtual

Hosted by Harvard OTD and the HMS Dept. of Biomedical Informatics, this month's speaker is Kathy Giusti, founder of the Multiple Myeloma Research Foundation. This series is a monthly conversation about medicine, biology, computers, and entrepreneurship. Open to all.